Diethylene glycol mono-n-butyl ether (DGBE) is a glycol ether solvent used in many consumer products including hard-surface cleaners and paints; its acetate ester (DGBA) is also used in paints. The highest consumer exposure to DGBE was estimated to be about 0.06 mg/kg/day from use in cleaners, and to DGBA was 0.19 mg/kg/day by inhalation from use in paints. DGBA was shown to be rapidly metabolized to DGBE, and its systemic toxicity was considered to be similar to DGBE. Prior toxicology studies and those required by a 1988 TSCA Final Test Rule, detailed in the following four papers, confirm that DGBE (and by implication DGBA): (1) can be absorbed dermally, (2) is not genotoxic in a battery of assays, (3) is not a systemic nor a reproductive toxicant by the dermal route in rats, and (4) is not neurotoxic by the dermal route in rats. There is an adequate margin of safety between the no observed adverse effect level in the animal studies and the estimated human exposure levels, confirming that there is no risk of systemic toxicity from the use of DGBE or DGBA in consumer products.
The subchronic and reproductive toxicity of diethylene glycol butyl ether (DGBE) by the dermal route was evaluated in Sprague-Dawley rats using a novel combined protocol. DGBE was administered dermally at 10 or 30% v/v in aqueous solutions or undiluted (100%) for 13 weeks under occlusion, 6 hr/day, 5 days/week at a maximum attainable volume of 2 mL/kg. Satellite groups of male and female rats were treated with the top dose of DGBE for 13 weeks, mated, and the females were treated through day 20 of gestation and allowed to deliver and nurse their offspring through day 21 of lactation (weaning). DGBE produced dermal irritation, which was dependent on concentration in incidence, severity, and time of onset and was more severe in females than in males. No corresponding histopathology was evident. The only suggestion of a systemic effect was a slightly increased incidence of urinary occult blood at study termination in the females receiving the 30% or 100% DGBE dose. There was no evidence of histopathologic changes in the testes, and vaginal cytology indicated no adverse effect on estrous cycling. There were no effects on reproductive performance of the DGBE-treated males and females. Litters delivered by treated females contained the same number of live pups as control litters and the growth and survival of pups within the treated litters was comparable to control. No reproductive or systemic toxicity was observed at the highest dose tested—2 g/kg/day.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.